Allegan Patients Included in the TIF® US Registry
Recent data from the Transoral Incisionless Fundoplication (TIF®) registry show that outcomes from the procedure observed at 6-months remained stable across a range of evaluation methodologies at 12-month follow-up. The one-year findings showed that 78 percent of patients experienced elimination of troublesome heartburn symptoms and 83 percent stopped experiencing regurgitation. Seventy-four percent of patients completely stopped medical therapy with proton pump inhibitor medications.
“This data contributes significantly to the body of evidence that the TIF procedure is able to control troublesome symptoms of GERD patients for an extended period of time,” said Dr. David Dargis, general surgeon at Allegan General Hospital and a participant in the TIF Registry study. “When a procedure allows patients to significantly reduce or completely eliminate their use of PPI therapy, they can avoid a range of potential harmful long-term side effects.”
The results were recently published in the February 2014 issue of the journal Surgical Laparoscopy Endoscopy and Percutaneous Techniques. The data show that quality-of-life scores remained the same or slightly improved over time, suggesting durability of outcomes between 6- and 12-month follow-up.
The publication reports results following TIF procedures in 100 consecutive patients enrolled in the registry and treated at 14 U.S. centers, which included Allegan Surgical Associates and Allegan General Hospital. The study was designed to assess the impact of the TIF procedure on patients with chronic GERD at 12-month follow-up. Patient follow-up is ongoing for this registry study.
Click here to review the study published in Surgical Laparoscopy Endoscopy and Percutaneous Techniques.